title: Patent ductus arteriosus: how important to which babies?
abstract: An overview is presented of 21 randomised controlled trials of either surgical closure of the ductus arteriosus or indomethacin therapy in preterm infants. All trials included backup treatment if the ductus arteriosus persisted. Overall, there is no significant effect on mortality or chronic lung disease. In trials treating at a presymptomatic stage, there is a trend to reduce the incidence of chronic lung disease. Early treatment with indomethacin reduces the incidence of periventricular haemorrhage. An ultrasound study of 110 very low birth weight infants showed ductus arteriosus size at 3 days to be related to factors reflecting the infants' condition (ventilation indices, blood product administration), but not to birth weight or gestational age. Infants with a moderate to large ductus arteriosus at 3 days had a significantly lower blood pressure from 12 h of age onwards than those with a closed or small ductuses.
authors.affiliation: Department of Paediatrics, National Women's Hospital, Auckland, New Zealand.
authors.forename: D B
authors.initials: DB
authors.lastname: Knight
mesh_terms: D004374:Ductus Arteriosus, Patent / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007022:Hypotension / Q000209:etiology; D015994:Incidence; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D015201:Meta-Analysis as Topic; D016032:Randomized Controlled Trials as Topic